We are live on ! Find out more
GC

GMT Capital Portfolio holdings

AUM $2.19B
1-Year Est. Return 72.3%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+72.3%
3 Year Est. Return
+172.46%
5 Year Est. Return
+183.05%
10 Year Est. Return
+942.8%
AUM
$2.64B
AUM Growth
+$95M
Cap. Flow
-$60.6M
Cap. Flow %
-2.29%
Top 10 Hldgs %
58.25%
Holding
105
New
20
Increased
23
Reduced
16
Closed
11

Top Buys

Rank Stock Value
1
VRN
Veren
VRN
+$27.7M
2
SIG icon
Signet Jewelers
SIG
+$19.4M
3
HBM icon
Hudbay
HBM
+$17.5M
4
CMA
Comerica
CMA
+$14M
5
BTG icon
B2Gold
BTG
+$12.6M

Top Sells

Rank Stock Value
1
HUN icon
Huntsman Corp
HUN
+$55.9M
2
SNX icon
TD Synnex
SNX
+$28.6M
3
WBD icon
Warner Bros
WBD
+$23.8M
4
PVH icon
PVH
PVH
+$21.4M
5
FXI icon
iShares China Large-Cap ETF
FXI
+$18.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.18%
2 Industrials 23.04%
3 Materials 22.9%
4 Technology 9.18%
5 Communication Services 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRPT icon
26
Freshpet
FRPT
$2.8B
$18.7M 0.71%
283,800
– –
OEC icon
27
Orion
OEC
$397M
$18.4M 0.7%
866,700
+127,800
+17% +$3.08M
MRNS
28
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$16.9M 0.64%
1,554,995
+373,425
+32% +$3.2M
NAMS icon
29
NewAmsterdam Pharma
NAMS
$3.47B
$16.5M 0.62%
1,383,800
+300,000
+28% +$3.98M
SYF icon
30
Synchrony
SYF
$24.7B
$15.8M 0.6%
464,400
-133,600
-22% -$4.08M
PLTR icon
31
Palantir
PLTR
$323B
$15.6M 0.59%
1,017,400
– –
CMA
32
DELISTED
Comerica
CMA
$14.6M 0.55%
+345,500
New +$14M
KLRS
33
Kalaris Therapeutics
KLRS
$95.2M
$14M 0.53%
178,438
+33,497
+23% +$3.18M
GTE icon
34
Gran Tierra Energy
GTE
$235M
$12.2M 0.46%
2,488,831
+78,600
+3% +$520K
CHWY icon
35
Chewy
CHWY
$9B
$11.5M 0.44%
292,600
– –
AMLX icon
36
Amylyx Pharmaceuticals
AMLX
$1.94B
$9.94M 0.38%
+461,000
New +$12.5M
WBD icon
37
Warner Bros
WBD
$64.8B
$9.78M 0.37%
779,531
-1,834,700
-70% -$23.8M
FSLY icon
38
Fastly Inc
FSLY
$3.2B
$9.44M 0.36%
598,800
– –
NKLA
39
DELISTED
Nikola Corporation Common Stock
NKLA
$9.29M 0.35%
+224,404
New +$6.19M
VTYX
40
DELISTED
Ventyx Biosciences
VTYX
$9.2M 0.35%
+280,600
New +$9.67M
ANNX icon
41
Annexon
ANNX
$913M
$8.68M 0.33%
2,464,571
+1,055,874
+75% +$4.62M
RCKT icon
42
Rocket Pharmaceuticals
RCKT
$375M
$8.59M 0.32%
432,100
-74,000
-15% -$1.5M
TSM icon
43
TSMC
TSM
$2.09T
$8.06M 0.3%
79,900
– –
ANF icon
44
Abercrombie & Fitch
ANF
$4.2B
$6.56M 0.25%
+174,000
New +$4.96M
RBLX icon
45
Roblox
RBLX
$38.1B
$6.06M 0.23%
+150,400
New +$6.04M
AXP icon
46
American Express
AXP
$240B
$5.84M 0.22%
33,500
-25,200
-43% -$4.07M
CLNE icon
47
Clean Energy Fuels
CLNE
$478M
$5.41M 0.2%
1,090,378
– –
HA
48
DELISTED
Hawaiian Holdings, Inc.
HA
$5.18M 0.2%
480,950
– –
OKTA icon
49
Okta
OKTA
$25.8B
$5.06M 0.19%
73,000
– –
KODK icon
50
Kodak
KODK
$750M
$4.53M 0.17%
981,400
+905,759
+1,197% +$3.82M
1
2
3 4 5

Similar funds

CFM
Coronation Fund Managers Cape Town, South Africa $2.19B AUM 3.99% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
SQA
Simon Quick Advisors Morristown, New Jersey $2.19B AUM 17.29% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ALMGDA
AG2R La Mondiale Gestion d'Actifs Paris, France $2.2B AUM 26.68% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

GMT Capital's Q2 2023 Portfolio in Review

As of Q2 2023, GMT Capital held 105 positions worth $2.64B, up 3.7% from $2.55B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

GMT Capital's Q2 2023 filing shows 20 new, 23 increased, 16 reduced and 11 closed positions. Its largest new stake was Comerica: 345,500 shares worth $14.6M. The largest sale was Huntsman Corp, an estimated $55.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Materials.

  • GMT Capital's largest Q2 2023 buy was Comerica: 345,500 shares worth $14.6M.
  • GMT Capital added most to Veren in Q2 2023, an estimated $27.7M increase.
  • GMT Capital's biggest Q2 2023 reduction was TD Synnex, cutting an estimated $28.6M.
  • GMT Capital fully exited Huntsman Corp in Q2 2023, selling an estimated $55.9M.
  • GMT Capital's ten largest holdings make up 58% of its $2.64B portfolio in Q2 2023.
  • GMT Capital opened 20 new positions and closed 11 in Q2 2023.
  • GMT Capital's portfolio value rose 3.7% quarter-over-quarter to $2.64B.

Based on GMT Capital's 13F filing for Q2 2023, filed 10 Aug 2023.